Last quarter (Q4 2022), Pharmaust Limited's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Pharmaust Limited's net income was $―. See Pharmaust Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Total Revenue	$ ―	$ 3.38M	$ 2.14M	$ 3.20M	$ 3.67M	$ 2.87M
Cost of Revenue	$ ―	$ 314.34K	$ 225.32K	$ 246.16K	$ 333.63K	$ 289.32K
Gross Profit	$ ―	$ 3.07M	$ 1.92M	$ 2.95M	$ 3.34M	$ 2.58M
Operating Expense	$ ―	$ 5.82M	$ 4.71M	$ 5.12M	$ 5.53M	$ 5.50M
Operating Income	$ ―	$ -2.75M	$ -2.79M	$ -2.17M	$ -2.20M	$ -2.92M
Net Non Operating Interest Income Expense	$ ―	$ -87.97K	$ -64.27K	$ -115.20K	$ -30.02K	$ 8.55K
Other Income Expense	$ ―	$ 1.13M	$ 1.52M	$ 924.23K	$ 676.30K	$ 387.66K
Pretax Income	$ ―	$ -1.71M	$ -1.34M	$ -1.36M	$ -1.55M	$ -2.52M
Tax Provision	$ ―	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -1.71M	$ -1.34M	$ -1.36M	$ -1.55M	$ -2.52M
Basic EPS	$ ―	$ >-0.01	$ >-0.01	$ >-0.01	$ >-0.01	$ ―
Diluted EPS	$ ―	$ >-0.01	$ >-0.01	$ >-0.01	$ >-0.01	$ ―
Basic Average Shares	$ ―	$ 316.88M	$ 315.74M	$ 296.03M	$ 219.33M	$ ―
Diluted Average Shares	$ ―	$ 316.88M	$ 315.74M	$ 296.03M	$ 219.33M	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income From Continuing And Discontinued Operation	$ ―	$ -1.71M	$ -1.34M	$ -1.36M	$ -1.55M	$ -2.52M
Normalized Income	$ ―	$ -1.71M	$ -1.34M	$ -1.36M	$ -1.55M	$ -2.52M
Interest Expense	$ ―	$ 88.51K	$ 78.99K	$ 118.50K	$ 47.82K	$ 28.35K
EBIT	$ ―	$ -1.62M	$ -1.26M	$ -1.24M	$ -1.50M	$ -2.49M
EBITDA	$ ―	$ -1.30M	$ -958.36K	$ -968.86K	$ -1.33M	$ -2.37M

Currency in USD

Pharmaust Limited Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing